Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of 3TC/FTC in Partially Suppressive Antiretroviral Regimens: The Switch Study

NCT00152061 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00152061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00152061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of 3TC/FTC in Partially Suppressive Antiretroviral Regimens: The Switch Study
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2005
Completion date
August 31, 2005
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections